Insider Trading History of New Leaf Bpo Management Ii, L.l.c

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of New Leaf Bpo Management Ii, L.l.c since 2018. This trader's CIK number is 1740755. At the time of last reporting, New Leaf Bpo Management Ii, L.l.c was the 10% Owner of Harpoon Therapeutics, Inc.. (stock ticker symbol HARP). Also see all insider trading activities at Harpoon Therapeutics, Inc..

Note that in the past New Leaf BPO Management II, L.L.C also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Harpoon Therapeutics, Inc. (HARP) by New Leaf Bpo Management Ii, L.l.c

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2021 HARP 235,294 $3,999,998 0 $0 0 $0

Yearly summary of insider trading at Principia Biopharma Inc. (PRNB) by New Leaf Bpo Management Ii, L.l.c

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2019 PRNB 0 $0 300,000 $10,500,000 0 $0
2018 PRNB 270,000 $4,590,000 0 $0 0 $0


Insider trading activities at 2 companies by New Leaf Bpo Management Ii, L.l.c:

1. Harpoon Therapeutics, Inc. (HARP)

2. Principia Biopharma Inc. (PRNB)

Table 1. Insider trading of Harpoon Therapeutics, Inc. (HARP) by New Leaf Bpo Management Ii, L.l.c

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2021-01-11 HARP Buy 235,294 17.00 3,999,998

Table 2. Insider trading of Principia Biopharma Inc. (PRNB) by New Leaf Bpo Management Ii, L.l.c

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2019-08-13 PRNB Sale 300,000 35.00 10,500,000
2018-09-18 PRNB Buy 270,000 17.00 4,590,000

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by New Leaf Bpo Management Ii, L.l.c (10% Owner of Harpoon Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.